TMT Fusion Plate vs. Two Crossed Screws

Clinical Indication for First Metatarsal Joint Arthrodesis Clinical Trial

— TMT  

Official title:

TMT Fusion Plate vs. Two Crossed Screws - A Randomized Controlled Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02096146
• Other study ID #: TMT Fusion Plate
• Status: Terminated
• Phase: N/A
• Start date: October 2014
• Est. completion date: August 2016

Study information

• Verified date: August 2020
• Source: AO Innovation Translation Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will compare TMT Fusion Plate versus two crossed screws for the fixation of first tarsometatarsal joint arthrodesis. Patients who meet eligibility criteria will be randomly assigned to one of these two treatment options.

Description:

Tarsometatarsal joint arthrodesis is a common procedure which can be performed using various devices such as screws, plates or both. The Tarsometatarsal Fusion Plate from "DePuySynthes" is a new device designed to encourage bony fusion of the 1st TMT joint, and is expected to lead to earlier fusion compared to the current standard of care of using 2 crossed screws. This is expected, in turn, to result in an earlier reduction in pain and an earlier return to full activity. At this time there is insufficient data directly comparing outcome following surgery for patients treated with screws or plates, and a study protocol which produces a higher level of evidence is therefore necessary.

The main aim of this study is to compare patient-reported outcome following surgery for patients undergoing joint arthrodesis using the TMT Fusion plate versus screws only. It is expected that surgery will improve patient-reported outcome similarly for both treatment groups in the long-term, but that the improvement will occur earlier for the plate group. For this study patient-reported outcome will be assessed by the walking/standing and pain domain scores of the Manchester Oxford Foot Questionnaire (MOXFQ). An earlier improvement in any of these two domains would be considered to be valuable. The primary analysis will therefore compare the time to a minimal clinically relevant improvement for any of the two MOXFQ domains for patients treated with TMT fusion plate versus patients treated with only screws during the first 12 months following surgery.

An economic evaluation from a societal perspective will determine the incremental cost-effectiveness of the TMT fusion plate versus the 2 crossed screws technique for 1st TMT joint fusion. Therefore a randomized controlled trial will be conducted, where patient-reported outcomes as well as clinical outcome parameters will be assessed.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 12
• Est. completion date: August 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Age: between 18 and 65 years

• At least one of the following:

• 1st TMT arthritis

• hallux valgus (intermetatarsal angle (IM) 1-2 angle > 15° on plain x-ray)

• 1st ray hypermobility with or without flat foot

• Painful condition

• Ability to understand the content of the patient information / Informed Consent Form

• Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)

• Signed and dated IRB/EC-approved written informed consent

Exclusion Criteria:

• Active infection

• Previous surgery on the 1st ray of the same foot

• Previous non-union on the 1st ray of the same foot

• Clinical obvious arthritis in other joints of the lower extremities

• Purely seeking plastic surgery

• Peripheral vascular disease (e.g. advanced diabetes)

• Peripheral sensory neuropathy (e.g. advanced diabetes)

• Concurrent surgery of the contralateral foot

• Any previously medically unmanaged severe systemic disease

• Substance abuse that would preclude reliable assessment

• Prisoner

• Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Related Conditions & MeSH terms

• Clinical Indication for First Metatarsal Joint Arthrodesis

Intervention

Procedure:
• TMT Fusion plate
Patients are treated with TMT Fusion Plate a post-market device to encourage bony fusion of the 1st TMT joint.
• Two crossed screws
Patients are treated with two crossed screws.This procedure is a standard treatment for 1st TMT joint fusion.

Locations

Country	Name	City	State
Colombia	Centro Médico Imbanaco Cali	Cali
United Kingdom	Ian Winson	Bristol
United States	Mid Michigan Orthopedic Institute - East Lansing	East Lansing	Michigan
United States	NY Downtown Orthopedic Associates	New York	New York
United States	Summit Orthopedics	Woodbury	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
AO Clinical Investigation and Publishing Documentation

Countries where clinical trial is conducted

United States,  Colombia,  United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in the patient-reported MOXFQ	Outcome measures for the study focus on fully validated patient related outcome measures for the foot (MOXFQ).	Up to 4 weeks pre-operative, Discharge (up to 1 week post-operative), 2 week FU, 6 week FU, 3 month FU, 6 month FU, 12 month FU
Secondary	Development of bone healing assessed based on x-rays		6 and 12 weeks postoperative
Secondary	Reconstruction of the joint position based on x-rays		Pre-operative up to 4 weeks vs. post-operative up to 2 weeks
Secondary	Change in quality of life (EQ-5D)	Outcome measure of general health	Up to 4 weeks pre-operative, discharge (up to 1 week post-op), 2 weeks FU, 6 weeks FU, 3 months FU, 6 months FU, 12 months FU
Secondary	Weekly assessed weight bearing during weeks 6-12		3 months FU
Secondary	Complications related to implant or surgery	For the duration of the study complications are continuously recorded and not restricted to the defined follow up visits.	Starts with surgery and is continued until the end of the study (12 months FU)
Secondary	Documentation of medication and treatment costs	A cost diary to collect treatment costs is distributed and collected at the next FU visit.	Starts after surgery and is continued until the end of the study (12 months FU)